AGENUS INC Convertible Notes Payable
AGENUS INC (AGEN) had Convertible Notes Payable of $1.21 million as of 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2014-05-09
- 2014-03-31: Convertible Notes Payable $1.21M.
- 2013-12-31: Convertible Notes Payable $0.00.
| Period end | Convertible Notes Payable |
|---|---|
| 2014-03-31 | $1.21M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $0.00 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |